The PLATFORM Trial: An Insight into the Improved Value of Using FFRCT for Reduction of Invasive Angiographic Procedures

Journal Title: Heart Research – Open Journal - Year 2016, Vol 2, Issue 5

Abstract

Coronary CT Angiography (CCTA) has been widely used as a reliable non-invasive modality for the diagnosis of Coronary Artery Disease (CAD) due to its improved spatial and temporal resolution.1-5For patients with low to intermediate pre-test probability of CAD, CCTA is used as an effective gatekeeper for determination of downstream testing, such as invasive coronary angiography or functional imaging.6However, CCTA is mainly an anatomic test with excellent visualization of coronary anatomical structures and detection of coronary lumen stenosis, while providing little functional information of the coronary lesions. Despite high sensitivity and negative predictive value, CCTA has been reported to have moderate specificity and positive predictive value due to the high percentage of false positive rates, and this is especially apparent in the assessment of coronary arteries with heavy calcification. Studies have shown the limited diagnostic value of CCTA in diagnosing highly calcified coronary plaques.7-11Thus, an imaging technique able to detect ischemia-producing lesions is of paramount importance since coronary stenosis does not always translate to functional significance. Clinical decision making of whether patients should proceed to a revascularization procedure is based on the predictive functional effect of coronary stenosis, because no prognostic benefit of revascularization has been reported in the coronary lesions without functional significance.

Authors and Affiliations

Zhonghua Sun

Keywords

Related Articles

The PLATFORM Trial: An Insight into the Improved Value of Using FFRCT for Reduction of Invasive Angiographic Procedures

Coronary CT Angiography (CCTA) has been widely used as a reliable non-invasive modality for the diagnosis of Coronary Artery Disease (CAD) due to its improved spatial and temporal resolution.1-5For patients with low to i...

Three-Dimensional Printing-Generated Realistic Anatomy Models and Virtual Endoscopy-Enhanced Intravascular Assessment of Pathologies

Three-dimensional (3D) printing has become a widely used technique showing many medical applications which range from orthopedics and maxillofacial surgery to cardiovascular disease and tumor imaging.1-10 Computed tomogr...

Where are Cell-Based Therapies Heading? Current Limitations and Future Directions

Congestive heart failure (CHF) secondary to chronic coronary artery disease is a major cause of morbidity and mortality worldwide. Its prevalence is increasing despite advances in medical and device therapies. Adult stem...

Dimethyl Sulfoxide Reduces Microvascular Obstruction and Intramyocardial Hemorrhage in a Porcine Ischemia-Reperfusion Model

Background: Microvascular obstruction (MVO) and Intramyocardial hemorrhage (IMH) are associated with myocardial reperfusion injury and recognized as predictors of adverse left ventricular remodeling in acute myocardial i...

Nicorandil: What is Beyond the Anti-Anginal Action?

Incidence of Contrast Induced Nephropathy (CIN) among ischemic heart disease patients subjected to coronary catheterization is highly dependent on the kidney function before contrast media administration and relevant ris...

Download PDF file
  • EP ID EP558683
  • DOI 10.17140/HROJ-2-e005
  • Views 148
  • Downloads 0

How To Cite

Zhonghua Sun (2016). The PLATFORM Trial: An Insight into the Improved Value of Using FFRCT for Reduction of Invasive Angiographic Procedures. Heart Research – Open Journal, 2(5), 13-17. https://europub.co.uk/articles/-A-558683